92785 ⎘
Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
BIOMOLECULE-POLYMER-PHARMACEUTICAL AGENT CONJUGATES FOR DELIVERING THE PHARMACEUTICAL AGENT
#2CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNODULATORY AND ANTI-PROLIFERATIVE AGENTS
#3CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF
#4DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE
#5ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#6BIOMOLECULE-POLYMER-PHARMACEUTICAL AGENT CONJUGATES FOR DELIVERING THE PHARMACEUTICAL AGENT
#7ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#8N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#9METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE
#10NOVEL COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#11CYCLOPROPENE PHOSPHORAMIDITES AND CONJUGATES THEREOF
#12CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS
#13COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#14Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent
#15CANNABINOID DERIVATIVES
#16SULFUR AND AMIDE TROPOLONE INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES THEREFOR
#17Adamantanecarboxylic acid benzyl amide derivative compound and skin whitening composition comprising same
#18Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents
#19Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#20Methylmenthol derivative and cool-sensation imparter composition containing same
#21Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#22Synthetic ligands that modulate the activity of the RhlR quorum sensing receptor
#23ACTIVE INGREDIENT COMPOSITIONS COMPRISING N-ALKENOYL-N-ALKYLGLUCAMIDES AND THE USE THEREOF
#24Chemical tools for imaging phospholipase D activity
#25SHIP1 MODULATORS AND METHODS RELATED THERETO
#26Benzo annulenes as antiviral agents
#27SHIP1 modulators and methods related thereto
#28Methyl menthol derivative and cooling agent composition containing same
#29Adamantane derivative compound
#30Compounds that are S1P modulating agents and/or ATX modulating agents
#31Immunoregulatory agents
#32SHIP1 modulators and methods related thereto
#33Histone deacetylase inhibitors and compositions and methods of use thereof
#34Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#35SHIP1 MODULATORS AND METHODS RELATED THERETO
#36New positive allosteric modulators of nicotinic acetylcholine receptor
#37COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION
#38Substituted cyclohexane compounds
#39Oleanolic acid amidate derivatives, preparation methods and uses thereof
#40Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof
#41Process for preparing bicyclic amine derivatives
#42COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION
#43N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#44MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#45Beta-hydroxyalkylamides, method for their production and use thereof
#46Heterocyclic CETP inhibitors
#47PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY
#48Phthalanilate compounds and methods of use
#49Small-molecule modulators of Trp-p8 activity
#50Compounds, pharmaceutical compositions and uses thereof
#51β-hydroxyalkylamides, a method for production of same and use of same
#52Nuclear receptor binding agents
#53Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
#54Sphingosine kinase inhibitors
#55Compositions and methods for the treatment of disease associated with TRP-P8 expression
#56Small-molecule modulators of Trp-p8 activity
#57Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate
#58Methods and compositions for treatment of diabetes and dyslipidemia
#59Sphingosine kinase inhibitor prodrugs
#60TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS
#61MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#62Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
#63Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
#64Compounds, their syntheses, compositions, and methods to treat cancer
#651,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use
#66Modulators of G protein-coupled receptor 88
#67Beta-hydroxyalkylamides, a method for production of same and use of same
#68Carboxamide derivatives having cooling properties
#69Aniline analogs as glycogen synthase activators
#701-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds
#71Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof
#72TREATMENT OF METABOLIC SYNDROME WITH NOVEL AMIDES
#73Heterocyclic CETP inhibitors
#74NAPHTHALENE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#75Modulators of ATP-Binding Cassette Transporters
#76N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof
#77N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#78Amide derivatives and medicinal use thereof
#79Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents
#80PAI-1 inhibitor
#81Compounds that stimulate glucose utilization and methods of use
#82NEW TYROSINE DERIVATIVES AS PPARy MODULATORS
#83Novel Compounds Active as Muscarinic Receptor Antagonists
#84Photosensitizers for targeted photodynamic therapy
#85Cooling Compounds
#86Small-molecule modulators of TRP-P8 activity
#87Carboxylic acid amides provoking a cooling sensation
#88Sphingosine kinase inhibitors
#89Sulfonanilide analogs as selective aromatase modulators (SAMs)
#90Naphthalene compounds
#91Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor
#92Modulators of peroxisome proliferator activated receptors
#93Tyrosine derivatives as PPAR-γ-modulators
#94β-Benzyloxyaspartate derivatives with amino group on benzene ring
#95Small-molecule modulators of TRP-p8 activity
#96Method of Identifying Inhibitors of DHODH
#97Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
#98Cannabinoid receptor modulators
#99Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties
#100CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#101Heterocyclic CETP inhibitors
#102Substituted biphenyl compounds
#103Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof
#104Method of identifying inhibitors of DHODH
#105Sphingosine kinase inhibitors
#106N-substituted p-menthane carboxamides
#107Compounds that stimulate glucose utilization and methods of use
#108Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
#109Compounds that stimulate glucose utilization and methods of use
#110Phenylnaphthalene compounds
#111Treatment of male sexual dysfunction
#112Biphenyloxy-acids
#113Amido compounds and their use as pharmaceuticals
#114N-acylamino benzyl ether derivatives
#115Cycloalkyl inhibitors of potassium channel function
#116Integrin receptor inhibitors
#117Compounds that stimulate glucose utilization and methods of use
#118Benzene derivatives and pharmaceutical use thereof
#119Modulators of ATP-binding cassette transporters
#120Trp-p8 active compounds and therapeutic treatment methods
#121Compositions and methods for the treatment of disease associated with Trp-p8 expression
#122Modulators of peroxisome proliferator activated receptors